Menu
Menu
ADAKVEO ® (crizanlizumab-tmca) is indicated to reduce the frequency of vaso-occlusive crises (VOCs) in adults and pediatric patients, aged 16 years and older, with sickle cell disease.
ADAKVEO is administered by IV infusion over a period of 30 minutes at Weeks 0 and 2, then every 4 weeks.
Induction period (week 0, 2, ) – Speak With Doctor About Details
The most common side effects of Actemra include: upper respiratory tract infections (common cold, sinus infections), headache and increased blood pressure.
Actemra changes the way your immune system works. This can make you more likely to get infections or make any current infection worse. Some people have serious infections while taking Actemra, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body.
If you have or are a carrier of the hepatitis B virus (a virus that affects the liver), the virus may become active while you use Actemra. Your healthcare provider may do blood tests before you start treatment with Actemra and while you are using Actemra.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Actemra website.
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.
